Compare DuPont de Nemours Inc (DD) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance

DuPont de Nemours IncTrade

IDEXX Laboratories, Inc.Trade

Price performance (Past 24H)

Key statistics

DuPont de Nemours Inc vs IDEXX Laboratories, Inc. — how do they compare? DuPont de Nemours Inc trades at $133.49 (market cap $18.12B), while IDEXX Laboratories, Inc. trades at $563.92 (market cap $42.65B). The key difference: IDEXX Laboratories, Inc. is far larger — about 2.4× DuPont de Nemours Inc's market cap, and DuPont de Nemours Inc pays a 1.79% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.

	DD	IDXX
Market Cap	$18.12B	$42.65B
Sector	Basic Materials	Health
52-Week High	$154.59	$766.68
52-Week Low	$87.72	$514.61
Enterprise Value	$20.58B	$43.56B
Dividend Yield	1.79%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

DuPont de Nemours Inc

No Aura AI signal available yet.

IDEXX Laboratories, Inc.

IDXX trades at $564.09, up 0.09% with neutral technical signals. The stock shows strong fundamentals with revenue growth to $4.3B in 2025 and consistent earnings beats. Analyst consensus is bullish (59% Buy) with improving cash flow trends. Recent news highlights AI integration in medical devices and upcoming Q2 2026 earnings.

Outlook remains positive driven by innovation and market leadership in pet healthcare. Risks include high valuation multiples and competitive pressures. Institutional sentiment supports growth, but investors should monitor execution against elevated expectations.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DuPont launches advanced Direct Lithium Extraction portfolio to boost lithium recovery from diverse brine sources.PRNewsWire · 6 hours agoBullish DuPont to announce Q2 2026 earnings on August 4 with live webcast and conference call.PRNewsWire · 1 day agoNeutral View details →

IDXX

Veterinary lab automation market to grow to $1.9B by 2030, driven by AI and companion animal care demandResearchandmarkets.Com · 2 days agoBullish Veterinary lab automation market to grow to $1.9B by 2030, driven by AI, robotics, and rising pet care demandGlobe News Wire · 2 days agoBullish View details →

About DuPont de Nemours Inc

DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics and communication, automotive, construction, safety and protection, and water management industries. DuPont benefits from the ability to produce patented specialty chemicals that command pricing power. Noteworthy products include Kevlar, Tyvek, and Nomex have evolved over time to enable a wide range of applications across multiple industries.

About IDEXX Laboratories, Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.